Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2014


Pharmaceutical Microbiology

21 Jan 2014 - 22 Jan 2014 - London, UK



Bookmark and Share


SMi’s reputable Pharamceutical Microbiology conference returns for its 3rd installment on 20th and 21st January, 2014, London UK.

Pharmaceutical Microbiology 2014 will draw upon the experiences and knowledge from experts and specialists around the globe to provide first-class presentations and stimulating discussions.

The conference will aim to focus on the regulatory aspect, with topics addressing preparations for auditing, what to expect during the inspection process, and how to rectify poor situations. There will also be considerable spotlight on novel rapid methods, case studies from the USA, their implementation, and the current regulatory view on methods. Among these hot topics the event will also examine sterility assessment, risk management, and contamination control.

KEY BENEFITS OF ATTENDING:

Regulatory body representation and update – what to expect from inspection, how to prepare your lab, and how to rectify situations when things go wrong.

Discover cutting edge rapid methods, how to implement the technology, and the regulatory stance

Hear specialist advice on contamination control and risk management to minimise costs and maximise efficiency

Learn about hot topics which include objectionable organisms, viral contaminations, update on the pharmacopeias, and quality by design.

Discuss case studies and experiences with expert speakers and delegates from across the UK, USA, and Europe.

KEY SPEAKERS:

Phil Duncanson, Site Microbiologist & QC Lead, MedImmune

Mary-Anne Weatherhead, Qualified Person, Pfizer

Andrew Bartko, Senior Scientist, Battelle

William Wade, Professor of Oral Microbiology, Barts and The London

Brendan Gilmore, Senior Lecturer in Pharmaceutical Microbiology, Queen’s University Belfast

Amy McDaniel, Associate Director, Production Operations, Pfizer

Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca

Pierre Raboisson, Head of Medicinal Chemistry, Johnson & Johnson

Olivier Chancel, Head of Pharmaceutical Support, Merial Sas (Sanofi)

Di Morris, Consultant, Pharmaceutical Solutions Ltd. (ex-MHRA)

Stephen Rawling, Microbiology Team Leader, GSK

John Duguid, Principal Process Analytical Scientist, Genzyme

Kim Bowers, Senior Supervisor, Pfizer

Hilary Chan, Quality Scientist IV, Pfizer

Erika Pfeiler, Microbiologist, FDA

Steven Donald, Microbiologist, FDA

The previous 2 events in the Microbiology series received positive feedback from the industry including Thermo Fischer Scientific – “The delegate quality was good” , Pfizer – “Topics were interesting and relevant” and Groninger & co gmbh- Very diverse multi facetted event

Be sure to take part in the next instalment by registering online at:

http://www.smi-online.co.uk/goto/2014pharma-microbiology29.asp

Alternatively contact John Collins on +44(0)20 7827 6734 or email jcollins@smi-online.co.uk


Further information
Scientific News
Combining Chemotherapy With Immune-Blocking Drug Could Stop Cancer Growing Back
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people.
Researchers Pioneer Use of Capsules to Save Materials
Wax capsule delivery systems can simplify a wide range of chemistry transformations.
Photoredox Catalyst Unlocks New Pathways for Nickel Chemistry
Using a light-activated catalyst, researchers have unlocked a new pathway in nickel chemistry to construct carbon-oxygen (C-O) bonds that would be highly valuable to pharmaceutical and agrochemical industries.
Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms
In a discovery with implications for future drug design scientists have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.
Familiar Drugs May Block Ebola Virus Infection
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus’s entry into cells and halt the disease in its tracks, according to researchers at the University of Illinois at Chicago.
New Extra ‘Sticky’ Microgel Could Revolutionise Bladder Cancer Treatment
Researchers have designed a new super-efficient way of delivering an anti-cancer drug which could extend and improve the quality of life for bladder cancer patients - and perhaps save lives.
Common Class of ‘Channel Blocking’ Drugs May Find a Role in Cancer Therapy
Discoveries in fruit flies prompt unusual treatment of patient with metastatic disease.
Common Medications Could Delay Brain Injury Recovery
Drugs used to treat common complaints could delay the recovery of brain injury patients according to research by University of East Anglia (UEA) and University of Aberdeen scientists, published today in Brain Injury.
Scientists Make Strides in Therapy Preventing Addiction Relapse
Single Injection of Drug Candidate Prevents Meth Relapse in Animal Models.
New Clot-Busting Treatments Target Number One Killer
Australian researchers funded by the National Heart Foundation are a step closer to a safer and more effective way to treat heart attack and stroke via nanotechnology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!